Capstone Investment Advisors
LEGN icon

Capstone Investment Advisors’s Legend Biotech LEGN Stock Holding History

Capstone Investment Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,399
Closed -$263K – 1937
2024
Q3 		$263K Sell
5,399
-1,078
-17% -$57.4K ﹤0.01% 1466
2024
Q2 		$287K Buy
+6,477
New +$299K ﹤0.01% 1597
2024
Q1 		– Sell
-4,599
Closed -$277K – 2454
2023
Q4 		$277K Sell
4,599
-2,663
-37% -$169K ﹤0.01% 1630
2023
Q3 		$488K Buy
+7,262
New +$504K ﹤0.01% 1337

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Capstone Investment Advisors's LEGN Position: Q4 2024 in Review

Capstone Investment Advisors sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 5,399 shares — an estimated $263K sold.

Capstone Investment Advisors first reported a position in LEGN in Q3 2023 and held it in 4 quarters. The position peaked at $488K in Q3 2023. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Capstone Investment Advisors reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 5,399 Legend Biotech shares in Q4 2024, an estimated $263K.
  • Capstone Investment Advisors first reported a position in Legend Biotech in Q3 2023 and held it in 4 quarters.
  • Capstone Investment Advisors's Legend Biotech position peaked at $488K in Q3 2023.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Capstone Investment Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.